NEOSEM INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,480 KRW | -7.10% |
|
-13.20% | +71.72% |
| 2023 | Neosem Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | Tranche Update on Neosem Inc.'s Equity Buyback Plan announced on June 29, 2022. | CI |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The group's high margin levels account for strong profits.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 64.81 and 23.9 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
Ratings chart - Surperformance
Sector: Semiconductor Equipment & Testing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +71.72% | 446M | - | - | |
| +46.73% | 120B | B- | ||
| +38.02% | 31.6B | A- | ||
| +42.65% | 24.84B | B- | ||
| +54.30% | 5.06B | C+ | ||
| +0.91% | 4.78B | D | ||
| +1.41% | 3.74B | D | ||
| -15.24% | 2.68B | D- | ||
| +160.77% | 1.18B | - | - | |
| +24.55% | 1.13B | - |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- A253590 Stock
- Ratings Neosem Inc.
